Work

A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer

Year: 2000

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1006388031954

Authors: G. Schwartsmann, H. Schunemann, C.N.F. Gorini, A.F. Ferreira Filho, C. Garbino, G. Sabini, I. Muse, L DiLeone, D.R. Mans

Institutions: Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Hospital de Clínicas, Universidade Luterana do Brasil

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W253251876

FWCI: 0.907

Cites: 23

Cited by: 111

Related to: 10